Dare Bioscience, Inc. — Director's Dealing 2023

Jun 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2023-06-21

Reporting Person: Matz Gregory W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-21	Stock Option (right to buy)	$0.96	A	40000	Acquired	2033-06-21	Common stock (40000)	Direct

Footnotes

F1: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.